Cancer Therapeutics-Related Cardiac Toxicity and Heart Failure: Current Evidence and Unresolved Challenges
As cancer survival continues to improve, cancer therapy-related cardiovascular toxicity, including cancer therapeutics-related cardiac dysfunction (CTRCD) and heart failure (HF), has emerged as a major clinical challenge. Growing evidence supports a bidirectional relationship between cancer and HF, driven by shared ris...